Filters: Keyword is Anti-HIV Agents [Clear All Filters]
"Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression." Journal of acquired immune deficiency syndromes (1999) 52, no. 3 (2009): 357-63. Abstract
"Effect of persistent moderate viremia on disease progression during HIV therapy." Journal of acquired immune deficiency syndromes (1999) 37, no. 1 (2004): 1147-54. Abstract
"Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana." BMC infectious diseases 13 (2013): 476. Abstract
"Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?" Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 13, no. 5 (2010): 535-42. Abstract
"Evaluation of multiple failure time analyses of observational data in patients treated for HIV." HIV clinical trials 6, no. 2 (2005): 81-91. Abstract
"Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 14, no. 10 (2010): 1244-51. Abstract
"Factors associated with retention and viral suppression among a cohort of HIV+ women of color." AIDS patient care and STDs 29 Suppl 1 (2015): S27-35. Abstract
"First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial." AIDS (London, England) 25, no. 4 (2011): 479-92. Abstract
"Global health and university patents." Science (New York, N.Y.) 301, no. 5640 (2003): 1629.
"Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel." Annals of internal medicine 156, no. 11 (2012): 817-33, W-284, W-285, W-286, W-287, W-288, W-289, W-290, W-291, W-292, W-293, W-294. Abstract
"Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
"Hepatitis C and the risk of kidney disease and mortality in veterans with HIV." Journal of acquired immune deficiency syndromes (1999) 53, no. 2 (2010): 222-6. Abstract
"High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study." Women & health 42, no. 2 (2005): 71-88. Abstract
"HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group." Journal of acquired immune deficiency syndromes (1999) 60 Suppl 1 (2012): S1-18. Abstract
"HIV and aging: time for a new paradigm." Current HIV/AIDS reports 7, no. 2 (2010): 69-76. Abstract
"HIV drug resistance and HIV transmission risk behaviors among active injection drug users." Journal of acquired immune deficiency syndromes (1999) 40, no. 1 (2005): 106-9. Abstract
"The HIV epidemic in Eastern Europe and Central Asia." Current HIV/AIDS reports 11, no. 2 (2014): 168-76. Abstract
"HIV infection and the risk of diabetes mellitus." AIDS (London, England) 23, no. 10 (2009): 1227-34. Abstract
"HIV infection, immunodeficiency, viral replication, and the risk of cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20, no. 12 (2011): 2551-9. Abstract
"HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S3-9. Abstract
"HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48, no. 6 (2009): 806-15. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36, no. 12 (2003): e162-4. Abstract
"Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans." AIDS education and prevention : official publication of the International Society for AIDS Education 21, no. 3 Suppl (2009): 40-53. Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"The impact of comprehensive prevention of mother-to-child HIV transmission in Dehong prefecture, Yunnan province, 2005-2010: a hard-hit area by HIV in Southern China." International journal of STD & AIDS 25, no. 4 (2014): 253-60. Abstract
"Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S48-53. Abstract
"The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life." Journal of acquired immune deficiency syndromes (1999) 47, no. 2 (2008): 185-93. Abstract
"Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile." Antimicrobial agents and chemotherapy 53, no. 11 (2009): 4640-6. Abstract
"The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access." AIDS and behavior 18, no. 2 (2014): 226-40. Abstract
"Implementation science of pre-exposure prophylaxis: preparing for public use." Current HIV/AIDS reports 7, no. 4 (2010): 210-9. Abstract
"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
"Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression." Journal of acquired immune deficiency syndromes (1999) 52, no. 2 (2009): 203-8. Abstract
"Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age." The Pediatric infectious disease journal 30, no. 10 (2011): 877-82. Abstract
"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model." Annals of internal medicine 148, no. 3 (2008): 178-85. Abstract
"The information-motivation-behavioral skills model of antiretroviral adherence and its applications." Current HIV/AIDS reports 5, no. 4 (2008): 193-203. Abstract
"The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample." AIDS and behavior 13, no. 1 (2009): 66-75. Abstract
"Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy." AIDS and behavior 12, no. 2 (2008): 284-93. Abstract
"Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration." Journal of acquired immune deficiency syndromes (1999) 69, no. 3 (2015): 348-54. Abstract
"Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission." American journal of public health 101, no. 3 (2011): 531-8. Abstract
"Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16, no. 8 (2012): 998-1004. Abstract
"Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
"Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy 57, no. 12 (2013): 6154-7. Abstract
"Involving behavioral scientists, health care providers, and HIV-infected patients as collaborators in theory-based HIV prevention and antiretroviral adherence interventions." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S10-7. Abstract
"Is it time for treatment as prevention among people who inject drugs?" Journal of acquired immune deficiency syndromes (1999) 63, no. 5 (2013): 545-7.
"Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 58, no. 9 (2014): 1312-21. Abstract
"Managing multiple and extensively drug-resistant tuberculosis and HIV." Expert opinion on pharmacotherapy 8, no. 8 (2007): 1035-7. Abstract
"Medical interventions for addictions in the primary care setting." Topics in HIV medicine : a publication of the International AIDS Society, USA 18, no. 1 (2010): 8-12. Abstract
"Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy." AIDS and behavior 17, no. 1 (2013): 113-21. Abstract
